Validation of a Multi-gene Test for Lung Cancer Risk

Active, not recruitingOBSERVATIONAL
Enrollment

403

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
Lung Cancer
Interventions
GENETIC

Lung Cancer Risk Test

Measurement of gene expression in normal bronchial epithelial cells obtained at time of bronchoscopy.

Trial Locations (13)

22042

Inova Fairfax Hospital, Falls Church

29425

Medical University of South Carolina, Charleston

37232

Tennessee Valley Veterans Admin., Nashville

Vanderbilt, Nashville

43221

Ohio State University, Columbus

43606

The Toledo Hospital, Toledo

43608

Mercy St. Vincent Medical Center, Toledo

43614

University of Toledo, Health Science Campus, Toledo

44195

Cleveland Clinic Foundation, Cleveland

48109

University of Michigan, Ann Arbor

48202

Henry Ford, Detroit

55905

Mayo Clinic, Rochester

80206

National Jewish Health, Denver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Toledo Health Science Campus

OTHER